Found: 15
Select item for more details and to access through your institution.
Cognitive functioning and treatment outcomes in a randomized controlled trial of internet-delivered drug and alcohol treatment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 1, p. e249744, doi. 10.1001/jamanetworkopen.2024.9744
- By:
- Publication type:
- Article
Buprenorphine Treatment for Opioid Use Disorder: An Overview.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
- Published in:
- Addiction Science & Clinical Practice, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13722-021-00223-z
- By:
- Publication type:
- Article
Predoctoral substance use disorders curricula: A survey analysis and experiential pedagogy.
- Published in:
- Journal of Dental Education, 2021, v. 85, n. 10, p. 1664, doi. 10.1002/jdd.12697
- By:
- Publication type:
- Article
Commentary on Foot et al.: Clinical considerations in addressing comorbid stimulant use in opioid use disorder.
- Published in:
- Addiction, 2024, v. 119, n. 1, p. 158, doi. 10.1111/add.16374
- By:
- Publication type:
- Article
The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study.
- Published in:
- Addiction, 2022, v. 117, n. 9, p. 2438, doi. 10.1111/add.15875
- By:
- Publication type:
- Article
Association between dynamic dose increases of buprenorphine for treatment of opioid use disorder and risk of relapse.
- Published in:
- Addiction, 2022, v. 117, n. 3, p. 637, doi. 10.1111/add.15654
- By:
- Publication type:
- Article
Cost‐effectiveness implications of increasing the efficiency of the extended‐release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis.
- Published in:
- Addiction, 2021, v. 116, n. 12, p. 3444, doi. 10.1111/add.15531
- By:
- Publication type:
- Article
Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables.
- Published in:
- Addiction, 2021, v. 116, n. 8, p. 2094, doi. 10.1111/add.15377
- By:
- Publication type:
- Article
Commentary on Stein et al. (2020): Whither detoxification in the face of the opioid epidemic?
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach.
- Published in:
- Journal of Multidisciplinary Healthcare, 2014, v. 7, p. 489, doi. 10.2147/JMDH.S49817
- By:
- Publication type:
- Article
Baseline- and treatment-associated pain in the X:BOT comparative effectiveness study of extended-release naltrexone versus buprenorphine-naloxone for OUD.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The utility of a formative one‐station objective structured clinical examination for Substance use disorders in a dental curriculum.
- Published in:
- European Journal of Dental Education, 2021, v. 25, n. 4, p. 813, doi. 10.1111/eje.12661
- By:
- Publication type:
- Article